Table 1.
Incident dyslipidemia by baseline demographic, behavioral and clinical characteristics, HIV patients on antiretroviral therapy, Vitoria, Brazil (n = 498).
| Variables | Dyslipidemiaa n (%) |
No dyslipidemia n (%) |
p-Value |
|---|---|---|---|
| Age (years) | |||
| 18–29 | 4 (3.6) | 24 (6.2) | 0.559 |
| 30–49 | 72 (64.9) | 239 (62.1) | |
| 50 or more | 35 (31.5) | 122 (31.7) | |
| Gender | |||
| Male | 62 (55.9) | 247 (63.8) | 0.149 |
| Female | 49 (44.1) | 140 (36.2) | |
| Education (years) | |||
| Up to 4 | 17 (15.3) | 39 (10.2) | 0.172 |
| More than 4 | 94 (84.7) | 344 (89.8) | |
| Tobacco use | |||
| Yes | 34 (31.5) | 139 (37.5) | 0.306 |
| No | 74 (68.5) | 232 (62.5) | |
| Nadir CD4+ (cells/mL) | |||
| Up to 200 | 68 (61.3) | 224 (59.1) | 0.742 |
| More than 200 | 43 (38.7) | 155 (40.9) | |
| Hypertension | |||
| Yes | 23 (20.7) | 71 (18.5) | 0.586 |
| No | 88 (79.3) | 312 (81.5) | |
| Previous diabetes | |||
| Yes | 3 (2.7) | 9 (2.3) | 0.945 |
| No | 108 (97.3) | 375 (97.7) | |
| HCV infection | |||
| Yes | 5 (4.5) | 24 (6.3) | 0.648 |
| No | 106 (95.5) | 357 (93.7) | |
Dyslipidemia: total cholesterol above 200 and HDL bellow 40 for men and 50 for women.